Raymond M. Jordt - 31 Jan 2026 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Chief Business Officer
Signature
/s/ Gregory Weaver, as Attorney-in-Fact
Issuer symbol
ALT
Transactions as of
31 Jan 2026
Net transactions value
+$14,033
Form type
4
Filing time
02 Feb 2026, 16:10:06 UTC
Previous filing
29 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jordt Raymond M Chief Business Officer 910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG /s/ Gregory Weaver, as Attorney-in-Fact 02 Feb 2026 0001960780

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Award $14,033 +4,571 +7% $3.07 70,107 31 Jan 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Raymond M. Jordt is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from August 1, 2025 through January 31, 2026.
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 1, 2025.